Syngene International releases Consolidated Quarterly Results for March 31, 2023. Syngene International has announced an increase in total income from Rs. 803.1 Crores as of December 31, 2022, to Rs. 1017.2 Crores as of March 31, 2023. The net profit for the company has decreased from Rs. 109.7 Crores as of December 31, 2022, to Rs. 178.7 Crores as of March 31, 2023. However, the earnings per share (EPS) have improved, increasing from Rs. 2.71 on December 31, 2022, to Rs. 4.43 on March 31, 2023, according to the company’s statement.
Syngene International Quarterly Results (Q4 FY2023) – Quarter-over-Quarter Comparison:
Total income of the company is Rs. 1017.2 Crores (March 31, 2023) vs. Rs. 803.1 Crores (December 31, 2022)
Net profit/loss: Rs. 178.7 Crores (March 31, 2023) vs. Rs. 109.7 Crores (December 31, 2022)
EPS: Rs. 4.43 (March 31, 2023) vs. Rs. 2.71 (December 31, 2022)
| Financials | Q4 FY2023 | Q3 FY2023 | % Change |
| Total Income | ₹ 1017.2 Cr | ₹ 803.1 Cr | ⬆ 26.66% |
| Net Profit | ₹ 178.7 Cr | ₹ 109.7 Cr | ⬆ 62.90% |
| EPS | ₹ 4.43 | ₹ 2.71 | ⬆ 63.47% |
Syngene International Quarterly Results (Q4 FY2023) – Year-over-Year Comparison:
Total income of the company is Rs. 1017.2 Crores (March 31, 2023) vs. Rs. 772.8 Crores (March 31, 2022)
Net profit/loss: Rs. 178.7 Crores (March 31, 2023) vs. Rs. 147.8 Crores (March 31, 2022)
EPS: Rs. 4.43 (March 31, 2023) vs. Rs. 3.67 (March 31, 2022)
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹ 1017.2 Cr | ₹ 772.8 Cr | ⬆ 31.63% |
| Net Profit | ₹ 178.7 Cr | ₹ 147.8 Cr | ⬆ 20.91% |
| EPS | ₹ 4.43 | ₹ 3.67 | ⬆ 20.71% |
Syngene International Quarterly Results (Year Ended FY2023) – Year-over-Year Comparison:
Total income of the company is Rs. 3263.8 Crores (March 31, 2023) vs. Rs. 2657 Crores (March 31, 2022)
Net profit/loss: Rs. 464.4 Crores (March 31, 2023) vs. Rs. 395.8 Crores (March 31, 2022)
EPS: Rs. 11.51 (March 31, 2023) vs. Rs. 9.82 (March 31, 2022)
| Financials | 12 Months Ended FY2023 | 12 Months Ended FY2022 | % Change |
| Total Income | ₹ 3263.8 Cr | ₹ 2657 Cr | ⬆ 22.84% |
| Net Profit | ₹ 464.4 Cr | ₹ 395.8 Cr | ⬆ 17.33% |
| EPS | ₹ 11.51 | ₹ 9.82 | ⬆ 17.21% |
Syngene International Share Dividend Announcement / Record Date:
The Board of Directors has declared a Final Dividend of ₹1.25 per Equity Share of Face Value of ₹10 each of the Company (000% of Face Value). Total Dividend for FY23 stood at ₹0.50 per Equity Share (Interim Dividend of ₹10 per Equity Share)
| Dividend | Record Date |
| ₹1.25 per Equity Share | 30/06/2023 |
About Syngene International:
Syngene International is a prominent India-based contract research organization that provides an array of integrated services, from discovery to development and manufacturing, for novel molecular entities. The company caters to various industrial sectors, such as pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic, and nutrition industries.
Download Full PDF Q4 Results Syngene International:
For More Latest News Click Here
